| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.062 | 0.3 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |